ChinaBio Partnering Forum EBD GroupChinaBIO
Share:
Email this page Share this on LinkedIn Share this on Twitter

ChinaBio® Partnering Forum 2014 Press Releases

May 14, 2014Sixth annual ChinaBio® Partnering Forum reports record attendance at Suzhou event ChinaBio® Partnering Forum 2014, China's largest life science partnering event, concluded last week in Suzhou, China with record attendance of 848 delegates from 425 companies, an increase of nearly 100 delegates over 2013. Delegates from 25 countries representing senior leadership in multinational pharmaceutical and large biotech drug development companies met with innovative...  more ►

April 28, 2014ChinaBio® Partnering Forum 2014 Program is uniquely designed for global life science companies seeking cross-border partnerships ChinaBio® Partnering Forum 2014, China's largest life science partnering event, will be held in one week, May 7–8, in Suzhou, China. The 2014 event kicks off with the widely acclaimed "Partnering Bootcamp: How to partner with global pharma," a special half-day global partnering bootcamp designed for entrepreneurs and executives in China to take their life science busines...  more ►

April 3, 2014Involvement of international pharmaceutical companies in ChinaBio® Partnering Forum 2014 echoes compelling China market demand The 2014 edition of ChinaBio® Partnering Forum, China's only life science partnering event, is just weeks away, to be held May 7–8 at the Kempinski Hotel in Suzhou. Pharma companies strongly support the event, as many international companies seek to access the massive healthcare market and partnership opportunities for growth in China. AstraZeneca, Bayer, Bristol-Myers S...  more ►

April 2, 2014Spotlight on Suzhou Business Facts BioBay innovation cluster BioBay, located in the Dushu Lake Science and Education Innovation District in Suzhou, is an innovative science and technology carrier for development of the emerging biological industry, among other initiatives. Currently there are over 400 biotech companies in BioBay. Suzhou Industrial Park The Suzhou Industrial Park (SIP) is the largest in China, a...  more ►

February 5, 2014China's largest life science partnering event returns to Suzhou, ChinaChinaBio® Partnering Forum 2014 to draw pharma and biotech dealmakers
The 2014 edition of ChinaBio® Partnering Forum, China's premier life science partnering event, will be held May 7–8 at the Kempinski Hotel in Suzhou. In 2013, the Forum was attended by more than 750 delegates from 405 companies and 22 countries, making it the largest partnering conference in China. Pharma and biotech companies as well as leading researchers from China's ...  more ►


partnering360® Blog

September 17, 2014 FierceBiotech’s 2014 Fierce 15 winners to be announced live at BioPharm America™ FierceBiotech’s annual list of the Fierce 15 involves a hunt for the biggest ideas in biotech, the most daring characters in biopharma, and entrepreneurs doing things that haven’t been done before. The result is fifteen privately held drug developers or platform biotechs with the potential... more ►

September 16, 2014 Innovation at Sanofi Sanofi looks for innovation in it’s drug portfolio in a variety of places – from the acquisitions they’ve made in their business to partnerships with venture capital, biotech and Pharma.  In a recent article at Insight, Gary J. Nabel, Senior VP, CSO and deputy to the President for... more ►

September 11, 2014 New therapeutic development models build researchers’ commercialization savvy Guest post from David Altman, Technology & Innovation Development Office, Boston Children’s Hospital Academic researchers and physician innovators are great at making research discoveries and developing inventions at an early stage. But if you were to fund them to turn their research... more ►

September 10, 2014 Broad Institute: Focus on cardiac arrhythmia Later this month at the BioPharm America™,  institutions from around the world will join us to present their latest innovations and discoveries. Today, we take a look at the Broad Institute and one of their latest innovative studies. Scientists came together to study heart arrhythmias and how... more ►

September 5, 2014 Building a Better Partnering Presentation Excerpts from “Building a Better Partnering Presentation” paper by Linda Pullan, PhD, of Pullan Consulting are republished here by permission from ShareVault® Whether seeking a partnership with another company to obtain funds, or looking to advance a drug candidate or technology, organizations... more ►



partnering360:Insight Latest headlines from partnering360:Insight

September 17, 2014 Vertex builds out BD group with sharp focus on in-licensing Both at BioPharm America™ in Boston and BIO-Europe® in Frankfurt, Vertex is on the hunt for research to late-stage development opportunities to further strengthen its pipeline through collaborations, part of a strategic shift meant to complement the ongoing internal research and development programs. more ►

September 9, 2014 Flagship Ventures explores the pharma innovation supply chain The care and feeding of the innovation supply chain is a primary focus for Flagship Ventures. While other venture capital firms are focusing on new financing options, this venture firm takes the more holistic approach of fostering innovation among early, disruptive platform companies—many of which they’ve created from scratch in-house—and forging relationships with larger firms that can take the platforms all the way to commercialization. more ►

September 5, 2014 Sanofi finds innovation in many places With ten therapeutic areas plus animal health, Sanofi’s R&D portfolio is well balanced to build upon the strengths of each of the franchises in its portfolio and to capitalize on innovative ideas and projects outside the company. more ►

August 13, 2014 Gene, stem cell therapies bring new players to partnering The next generation of therapies built upon the science of stem cells and genetics will require new types of partnerships. If there is promise that these technologies can redefine how we understand and treat disease, there is already a certainty that the alliances and partnerships required to bring these therapies to patients are also beyond traditional models for commercialization. more ►

August 1, 2014 J&J: “Innovation delivers growth and growth sustains our innovation” "What we are really trying to accomplish is building more than a financial relationship. We are interested in truly finding a way to get to the outcomes. We want to keep our partners intimately involved in a pursuit of truth, in understanding what this science means in the lives of patients who might benefit the most from it. It is this dialogue we are after." more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD Group, Inc.
Privacy Policy
Terms of Use
ChinaBio Partnering Forum EBD GroupChinaBIO